HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $100 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ: ARWR ) with a Buy and maintains $100 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.